ClinicalTrials.Veeva

Menu

Comparison of Quality of Life After Discharge of the Mild and Moderate COVID-19 Patients With or Without Herbal Medicine

U

University of Medicine and Pharmacy at Ho Chi Minh City

Status

Completed

Conditions

Quality of Life
COVID-19 Pandemic

Treatments

Drug: Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng)

Study type

Observational

Funder types

Other

Identifiers

NCT05228873
838-9/HĐĐĐ-ĐHYD

Details and patient eligibility

About

The purpose of this study is to see how the acute stage COVID-19 treatments by use of herbal medicine (Shen Cao Gan Jiang Tang) affect quality of life and symptoms at 3 months after hospital discharge.

Full description

According to the theory of Traditional medicine, the patient will suffer damage to Qi and Fluid in the acute phase and lead to damaged Yin and Qi in the post COVID-19 period.

The Shen Cao Gan Jiang Tang has the effect of enhance the Protective Qi, generating Fluid, is applied to treat the mild and moderate COVID-19 in the acute phase in some hospitals in Ho Chi Minh City, Viet Nam. The hypothesis is that with the use of the Shen Cao Gan Jiang Tang, the Qi and Yin will reduce the damage, so that the patient has a better quality of life and fewer post COVID-19 symptoms compared with the standard of care group

Enrollment

300 patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients able to understand and fill out a questionnaire
  • From full 18 to 64 years old;
  • Patients with the mild and moderate COVID-19 who used Shen Cao Gan Jiang Tang in the acute phase for intervention group.
  • Participants enrolled in protocol NCT05055427.
  • Voluntarily consented to participate in the study

Exclusion criteria

  • Patient who are not able to complete 100% of the questionnaire Criteria for stopping the study
  • The patient cannot be contacted after 04 calls, each call is at least 06 hours apart on the survey days.
  • The patient does not want to continue participating in the study.

Trial design

300 participants in 2 patient groups

Investigational arm
Description:
Patients take Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng), one bag of decoction (90ml) two times a day for 10 days plus the Standard of Care (SOC) for the treatment of COVID-19 acute stage based on the Vietnam Ministry of Health guideline at this time
Treatment:
Drug: Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng)
• Controlled arm
Description:
Patient who receive the Standard of Care (SOC) for the treatment of COVID-19 acute stage based on the Vietnam Ministry of Health guideline at this time

Trial contacts and locations

1

Loading...

Central trial contact

Nguyen Van Dan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems